Research: Efficacy of Solifenacin for Overactive Bladder Symptoms, Symptom Bother, and Health-Related Quality of Life in Patients by Duration of Self-Reported Symptoms: A Secondary Analysis of the VIBRANT Study
Identification:
unj_jf12_04
Issue:
January-February 2012
Volume:
Volume 32 Number 1
Acknowledgments and Author Contributions: The VIBRANT Study was undertaken with a research grant from Astellas Pharma U.S.; Inc. and GlaxoSmithKline. Editorial support; including writing assistance; was provided by Linda A. Goldstein; PhD; a medical writer at Envision Pharma; Inc.; and was funded by Astellas Pharma Global Development; Inc. and GlaxoSmithKline.